{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:07:15Z","timestamp":1788883635477,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Kidney Foundation Netherlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103065","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:23:38Z","timestamp":1787153018000},"page":"103065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2111-3296","authenticated-orcid":false,"given":"Lo\u00efs A.K.","family":"van der Pluijm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Koudijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris I.","family":"Rotmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Bijkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103065_bib1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.103065_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/HYPERTENSIONAHA.119.12703","article-title":"Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen","volume":"73","author":"Uijl","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.omtn.2026.103065_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11906-025-01325-8","article-title":"Small Interfering RNA Therapy for the Management and Prevention of Hypertension","volume":"27","author":"Ren","year":"2025","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.omtn.2026.103065_bib4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/HYPERTENSIONAHA.120.16876","article-title":"Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease","volume":"77","author":"Bov\u00e9e","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.omtn.2026.103065_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bph.15955","article-title":"Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes","volume":"180","author":"Cruz-L\u00f3pez","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.omtn.2026.103065_bib6","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1681\/ASN.2015080877","article-title":"Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage","volume":"27","author":"Lichtnekert","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2026.103065_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11906-009-0080-z","article-title":"Novel mechanisms for the control of renin synthesis and release","volume":"12","author":"Sequeira Lopez","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.omtn.2026.103065_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajpath.2013.04.024","article-title":"Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease","volume":"183","author":"Pippin","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2026.103065_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1681\/ASN.2014030265","article-title":"Renin Lineage Cells Repopulate the Glomerular Mesangium after Injury","volume":"26","author":"Starke","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2026.103065_bib10","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1152\/ajprenal.00438.2014","article-title":"Cells of renin lineage are adult pluripotent progenitors in experimental glomerular disease","volume":"309","author":"Pippin","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.omtn.2026.103065_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1113\/JP282615","article-title":"Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys","volume":"600","author":"Broeker","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.omtn.2026.103065_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12882-015-0216-0","article-title":"Cells of renin lineage express hypoxia inducible factor 2\u03b1 following experimental ureteral obstruction","volume":"17","author":"Stefanska","year":"2016","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.omtn.2026.103065_bib13","doi-asserted-by":"crossref","first-page":"C1429","DOI":"10.1152\/ajpcell.00427.2025","article-title":"Targeting microRNA-132 protects against kidney fibrosis and restricts myofibroblast differentiation from cells of renin lineage","volume":"329","author":"van der Pluijm","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omtn.2026.103065_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14108","article-title":"SGLT2 inhibition promotes glomerular repopulation by cells of renin lineage in experimental kidney disease","volume":"240","author":"van der Pluijm","year":"2024","journal-title":"Acta Physiol."},{"key":"10.1016\/j.omtn.2026.103065_bib15","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00065.2008","article-title":"Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination","volume":"295","author":"Piecha","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.omtn.2026.103065_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.117.09755","article-title":"Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury","volume":"70","author":"Mullick","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.omtn.2026.103065_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.kint.2023.04.019","article-title":"Progenitor hierarchy among parietal epithelial cells depicted at the single-cell level","volume":"104","author":"Romagnani","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2026.103065_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154337","article-title":"Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans","volume":"6","author":"Watanabe","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2026.103065_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/CIRCRESAHA.124.325305","article-title":"Transformation of the Kidney into a Pathological Neuro-Immune-Endocrine Organ","volume":"135","author":"Yamaguchi","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2026.103065_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038326","article-title":"Kidney Arteriolar Responses to Liver-Targeted Small Interference RNA Targeting Angiotensinogen in Diabetic Rats: Comparison With Other Renin-Angiotensin System Blockers","volume":"14","author":"Cruz-L\u00f3pez","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2026.103065_bib21","series-title":"Generation of Renin BAC Transgenic Models for the Study of Regulation, Lineage Tracing, and Tumorigenic Potential of the Renin-Expressing Cell (Dissertation)","author":"Glenn","year":"2014"},{"key":"10.1016\/j.omtn.2026.103065_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1109\/TSMC.1978.4310039","volume":"8","year":"1978","journal-title":"IEEE Trans. Syst. Man Cybern."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:11:49Z","timestamp":1788880309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126002362"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103065","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103065"}}